MHC ANTIGENS AND CANCER - IMPLICATIONS FOR T-CELL SURVEILLANCE

被引：69
作者：
BROWNING, MJ
BODMER, WF
机构：
[1] Imperial Cancer Reserach Fund, Institute of Molecular Medicine, John Radcliffe Hospital, Oxford
来源：
CURRENT OPINION IN IMMUNOLOGY | 1992年 / 4卷 / 05期
关键词：
D O I：
10.1016/0952-7915(92)90036-E
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Evidence for a direct involvement of cell-mediated immune mechanisms in the control of human tumours remains sketchy. The past year, however, has seen advances in our understanding of the relationship between the immune system and tumour cells, and has given rise to new prospects for immunological treatment and the prevention of cancers.
引用
收藏
页码：613 / 618
页数：6
相关论文
共 57 条
[1]  
Amiel JL, 1967, HISTOCOMPATIBILITY T, P79
[2]  
ANICHINI A, 1989, J IMMUNOL, V142, P3692
[3]   CLONAL ANALYSIS OF THE CYTOLYTIC T-CELL RESPONSE TO HUMAN-TUMORS [J].
ANICHINI, A ;
FOSSATI, G ;
PARMIANI, G .
IMMUNOLOGY TODAY, 1987, 8 (12) :385-389
[4]   ON A POSSIBLE PROTECTIVE EFFECT OF HLA-A11 AGAINST SKIN-CANCER AND KERATOTIC SKIN-LESIONS IN RENAL-TRANSPLANT RECIPIENTS [J].
BAVINCK, JNB ;
KOOTTE, AMM ;
VANDERWOUDE, FJ ;
VANDENBROUCKE, JP ;
VERMEER, BJ ;
CLAAS, FHJ .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1991, 97 (02) :269-272
[5]   RELATION BETWEEN SKIN-CANCER AND HLA ANTIGENS IN RENAL-TRANSPLANT RECIPIENTS [J].
BAVINCK, JNB ;
VERMEER, BJ ;
VANDERWOUDE, FJ ;
VANDENBROUCKE, JP ;
SCHREUDER, GMT ;
THOROGOOD, J ;
PERSIJN, GG ;
CLAAS, FHJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (12) :843-848
[6]  
BODMER JG, 1989, LANCET, V1, P1455
[7]  
BODMER JG, 1992, IN PRESS HISTOCOMPAT
[8]  
BODMER W, 1992, CANCER SURV, V13, P1
[9]  
BROUSSET P, 1991, BLOOD, V77, P1781
[10]   HUMAN PAPILLOMAVIRUS TYPE-16 NUCLEOPROTEIN-E7 IS A TUMOR REJECTION ANTIGEN [J].
CHEN, LP ;
THOMAS, EK ;
HU, SL ;
HELLSTROM, I ;
HELLSTROM, KE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (01) :110-114
123456